PYC Therapeutics Limited (ASX: PYC)
Australia
· Delayed Price · Currency is AUD 0.190
0.00 (0.00%)
Nov 14, 2024, 4:10 PM AEST
PYC Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | -37.73 | -37.73 | -22.79 | -13.86 | -17.77 | -6.82 | Upgrade
|
| Depreciation & Amortization | 1.07 | 1.07 | 0.88 | 0.84 | 0.62 | 0.55 | Upgrade
|
| Stock-Based Compensation | 0.25 | 0.25 | -0.07 | 0.61 | 3.63 | 0.72 | Upgrade
|
| Other Operating Activities | -0.4 | -0.4 | -0.48 | -0.43 | -0.86 | -0.25 | Upgrade
|
| Change in Accounts Receivable | -2.44 | -2.44 | -6.16 | -9.83 | -0.13 | -0.1 | Upgrade
|
| Change in Accounts Payable | 0.39 | 0.39 | 4.34 | 0.17 | 2.5 | 0.02 | Upgrade
|
| Change in Other Net Operating Assets | 0.28 | 0.28 | -0.14 | 0.73 | 0.22 | 0.13 | Upgrade
|
| Operating Cash Flow | -38.59 | -38.59 | -24.42 | -21.78 | -11.79 | -5.75 | Upgrade
|
| Capital Expenditures | -0.31 | -0.31 | -0.49 | -0.39 | -0.59 | -0.11 | Upgrade
|
| Investment in Securities | - | - | - | 33.07 | -14.88 | -13.67 | Upgrade
|
| Other Investing Activities | - | - | 0.01 | - | -0.05 | - | Upgrade
|
| Investing Cash Flow | -0.31 | -0.31 | -0.48 | 32.68 | -15.52 | -13.77 | Upgrade
|
| Long-Term Debt Repaid | -0.29 | -0.29 | -0.23 | -0.18 | -0.23 | -0.15 | Upgrade
|
| Net Debt Issued (Repaid) | -0.29 | -0.29 | -0.23 | -0.18 | -0.23 | -0.15 | Upgrade
|
| Issuance of Common Stock | 92.06 | 92.06 | 12.65 | - | 41.08 | 26.88 | Upgrade
|
| Other Financing Activities | -1.57 | -1.57 | -0.98 | - | -2.29 | -1.62 | Upgrade
|
| Financing Cash Flow | 90.19 | 90.19 | 11.44 | -0.18 | 38.56 | 25.11 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | 0 | -0.08 | -0.04 | -0.05 | -0.01 | Upgrade
|
| Net Cash Flow | 51.3 | 51.3 | -13.54 | 10.67 | 11.19 | 5.58 | Upgrade
|
| Free Cash Flow | -38.9 | -38.9 | -24.91 | -22.17 | -12.38 | -5.85 | Upgrade
|
| Free Cash Flow Margin | -176.32% | -176.32% | -157.61% | -138.19% | -402.76% | -244.37% | Upgrade
|
| Free Cash Flow Per Share | -0.10 | -0.10 | -0.08 | -0.07 | -0.04 | -0.02 | Upgrade
|
| Cash Interest Paid | 0.05 | 0.05 | 0.03 | 0.03 | 0.04 | 0.04 | Upgrade
|
| Cash Income Tax Paid | -16.46 | -16.46 | -9.67 | -6 | -3.07 | -2.4 | Upgrade
|
| Levered Free Cash Flow | -25.18 | -25.18 | -16.4 | -16.72 | -5.68 | -3.38 | Upgrade
|
| Unlevered Free Cash Flow | -25.15 | -25.15 | -16.39 | -16.7 | -5.65 | -3.35 | Upgrade
|
| Change in Net Working Capital | 1.87 | 1.87 | 2.06 | 8.84 | -2.41 | -0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.